INNOVENT BIO (01801) Announces Monthly Return for February 2026

Bulletin Express03-05

Innovent Biologics, Inc. submitted its monthly return for February 2026 on 05 March 2026. The authorized share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each, reflecting a total authorized capital of USD 50,000. The number of issued shares stood at 1.74 billion with no movement during the month, and the public float requirement remained fully compliant as of the end of February.

In terms of share option schemes, the Pre-IPO Share Incentive Plan, Post-IPO share option scheme, and 2024 Share Scheme recorded no share issuances. Options outstanding under each scheme showed minimal numerical changes but did not result in the issuance of new shares or transfers of treasury shares. No warrants, convertibles, or other share issuance arrangements were executed during the period, and there were no share repurchases or cancellations reported.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197012654?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 20:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197012654","market":"hk","top_or_hot":-1,"title":"INNOVENT BIO (01801) Announces Monthly Return for February 2026","media":"Bulletin Express","content":"<p>Innovent Biologics, Inc. submitted its monthly return for February 2026 on 05 March 2026. The authorized share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each, reflecting a total authorized capital of USD 50,000. The number of issued shares stood at 1.74 billion with no movement during the month, and the public float requirement remained fully compliant as of the end of February.</p>\n<p>In terms of share option schemes, the Pre-IPO Share Incentive Plan, Post-IPO share option scheme, and 2024 Share Scheme recorded no share issuances. Options outstanding under each scheme showed minimal numerical changes but did not result in the issuance of new shares or transfers of treasury shares. No warrants, convertibles, or other share issuance arrangements were executed during the period, and there were no share repurchases or cancellations reported.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INNOVENT BIO (01801) Announces Monthly Return for February 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINNOVENT BIO (01801) Announces Monthly Return for February 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 20:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Innovent Biologics, Inc. submitted its monthly return for February 2026 on 05 March 2026. The authorized share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each, reflecting a total authorized capital of USD 50,000. The number of issued shares stood at 1.74 billion with no movement during the month, and the public float requirement remained fully compliant as of the end of February.</p>\n<p>In terms of share option schemes, the Pre-IPO Share Incentive Plan, Post-IPO share option scheme, and 2024 Share Scheme recorded no share issuances. Options outstanding under each scheme showed minimal numerical changes but did not result in the issuance of new shares or transfers of treasury shares. No warrants, convertibles, or other share issuance arrangements were executed during the period, and there were no share repurchases or cancellations reported.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01801","symbol_name":"信达生物","start_time":0,"source_url":"","article_id":"1197012654","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197012654","pubTimestamp":1772714680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Innovent Biologics, Inc. submitted its monthly return for February 2026 on 05 March 2026. The authorized share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01801":"信达生物"},"translate_title":"信达生物(01801)公布2026年2月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01801":1},"content_text":"Innovent Biologics, Inc. submitted its monthly return for February 2026 on 05 March 2026. The authorized share capital remained at 5.00 billion ordinary shares with a par value of USD 0.00001 each, reflecting a total authorized capital of USD 50,000. The number of issued shares stood at 1.74 billion with no movement during the month, and the public float requirement remained fully compliant as of the end of February.\nIn terms of share option schemes, the Pre-IPO Share Incentive Plan, Post-IPO share option scheme, and 2024 Share Scheme recorded no share issuances. Options outstanding under each scheme showed minimal numerical changes but did not result in the issuance of new shares or transfers of treasury shares. No warrants, convertibles, or other share issuance arrangements were executed during the period, and there were no share repurchases or cancellations reported.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197012654","isCrawlerRequest":true}